Basal cell carcinoma is a form of skin cancer caused by regular sun exposure, or other ultraviolet radiation, which starts in the top layer of the skin (epidermis), is usually painless and grows slowly. The U.S. Food and Drug government just approved a new drug named Erivedge (vismodegi for the care of adult clientele with basal cell carcinoma, the most common type of skin cancer. The drug is designed for use in career with locally farthest basal cell cancer, whose cancer has spread to other locations in the body, and who are unsuitable competitors for surgery or radiation...

More: - Brought to my attention by